M&A

Roche pays $250 million to acquire Good Therapeutics and its preclinical cancer therapy
Stat
Wed, 09/7/22 - 10:45 am
Roche
M&A
Good Therapeutics
cancer
oncology
Merck's Deal With Seagen May Have Fallen Through. Now What?
Motley Fool
Wed, 09/7/22 - 10:16 am
Merck
Seagen
M&A
EU swats down Illumina's $8B Grail acquisition days after FTC lost antitrust case
Endpoints
Tue, 09/6/22 - 10:36 am
Europe
Illumina
Grail
FTC
M&A
Illumina defeats F.T.C. in major antitrust case
NY Times, NY
Thu, 09/1/22 - 07:46 pm
Illumina
FTC
Grail
M&A
antitrust
Novo Nordisk to acquire Forma Therapeutics in $1.1. bln deal
Yahoo/Reuters
Thu, 09/1/22 - 10:49 am
Novo Nordisk
Forma Therapeutics
M&A
blood disorders
Biotech startup Ocean pivots from IPO to SPAC merger
BioPharma Dive
Wed, 08/31/22 - 10:24 pm
Ocean Biomedical
IPOs
SPAC
M&A
Aesther Healthcare Acquisition Corp
Olympus to sell microscope unit for $3.1B as it bolsters focus on medical technology
Medtech Dive
Wed, 08/31/22 - 10:26 am
Medtech
devices
Olympus
microscopes
M&A
Bain Capital
Merck and Seagen can't agree on a price for their rumored merger
Fierce Pharma
Fri, 08/26/22 - 10:43 am
M&A
Merck
Seagen
Labcorp adds to hospital lab buying streak with New Jersey acquisition
Medtech Dive
Thu, 08/25/22 - 07:44 pm
Medtech
diagnostics
M&A
LabCorp
RWJBarnabas Health
Johnson & Johnson lost to Pfizer in bidding war for Global Blood Therapeutics: Bloomberg
Fierce Pharma
Wed, 08/24/22 - 10:34 am
Pfizer
JNJ
M&A
Global Blood Therapeutics
Aerie’s glaucoma drug journey ends in $770M sale to Alcon
BioPharma Dive
Tue, 08/23/22 - 10:40 am
Alcon
Aerie Pharmaceuticals
M&A
glaucoma
3 Biopharmas on Buyout Watch
Motley Fool
Mon, 08/22/22 - 10:39 am
M&A
Axsome Therapeutics
Alnylam Pharmaceuticals
Karuna Therapeutics
Biotech Looks to Bounce Back in Second Half of 2022
BioSpace
Mon, 08/22/22 - 09:43 am
biotech
M&A
drug approvals
Bristol Myers completes Turning Point Acquisition
Pharmaceutical Business Review
Thu, 08/18/22 - 10:50 am
Bristol Myers Squibb
M&A
Turning Point Therapeutics
oncogenesis
Seagen's (SGEN) Cancer Drugs Aid Growth, Stiff Rivalry a Woe
Yahoo/Zacks.com
Fri, 08/12/22 - 10:12 am
Seagen
Adcetris
Padcev
Tukysa
Tivdak
Merck
M&A
A complex fracturing at Bone brings together inflammatory, orthopedic biotechs in reverse merger-type deal
Fierce Biotech
Wed, 08/10/22 - 10:41 am
M&A
Bone Therapeutics
Medsenic
BioSenic
Orthopedics
Pfizer buys sickle cell drugmaker Global Blood for $5.4B
BioPharma Dive
Mon, 08/8/22 - 10:29 am
Pfizer
Global Blood Therapeutics
M&A
sickle cell disease
Oxbryta
Pfizer, riding high on COVID windfall, eyes $5B play for Global Blood Therapeutics
Fierce Pharma
Sun, 08/7/22 - 11:27 pm
Pfizer
Global Blood Therapeutics
M&A
Oxbryta
How a small UK biotech ended up in Gilead’s hands
BioPharma Dive
Sun, 08/7/22 - 11:18 pm
Gilead Sciences
MiroBio
M&A
University of Oxford
Gilead Sciences to acquire Oxford University biotech spinout MiroBio for $405M
TechCrunch
Thu, 08/4/22 - 06:41 pm
Gilead Sciences
M&A
University of Oxford
MiroBio

Pages